Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cyclin-dependent kinase 3 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | mitogen-activated protein kinase 5 | cyclin-dependent kinase 3 | 305 aa | 303 aa | 32.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Kinase, CMGC CDK | 0.0052 | 0 | 0.5 |
Mycobacterium leprae | Probable dihydroorotate dehydrogenase PyrD | 0.0326 | 1 | 0.5 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0127 | 0.2744 | 1 |
Leishmania major | dihydroorotate dehydrogenase | 0.0326 | 1 | 1 |
Entamoeba histolytica | dihydropyrimidine dehydrogenase, putative | 0.0127 | 0.2744 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0127 | 0.2744 | 1 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0127 | 0.2744 | 1 |
Loa Loa (eye worm) | CMGC/CDK/CDK5 protein kinase | 0.0052 | 0 | 0.5 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0127 | 0.2744 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0127 | 0.2744 | 1 |
Trypanosoma cruzi | dihydroorotate dehydrogenase (fumarate), putative | 0.0326 | 1 | 1 |
Plasmodium falciparum | dihydroorotate dehydrogenase | 0.0326 | 1 | 1 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.0326 | 1 | 1 |
Plasmodium vivax | dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.0326 | 1 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0127 | 0.2744 | 1 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0127 | 0.2744 | 1 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.0127 | 0.2744 | 0.2744 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0052 | 0 | 0.5 |
Trypanosoma brucei | dihydroorotate dehydrogenase (fumarate) | 0.0326 | 1 | 1 |
Brugia malayi | Zinc finger, C2H2 type family protein | 0.0127 | 0.2744 | 0.2744 |
Trichomonas vaginalis | dihydropyrimidine dehydrogenase, putative | 0.0127 | 0.2744 | 1 |
Mycobacterium ulcerans | dihydroorotate dehydrogenase 2 | 0.0326 | 1 | 0.5 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.0326 | 1 | 1 |
Schistosoma mansoni | dihydroorotate dehydrogenase | 0.0326 | 1 | 1 |
Brugia malayi | Dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.0326 | 1 | 1 |
Mycobacterium tuberculosis | Probable dihydroorotate dehydrogenase PyrD | 0.0326 | 1 | 0.5 |
Toxoplasma gondii | dihydroorotate dehydrogenase reveal, putative | 0.0326 | 1 | 1 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0052 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | dihydroorotate dehydrogenase 2 | 0.0326 | 1 | 0.5 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0127 | 0.2744 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0127 | 0.2744 | 1 |
Giardia lamblia | Kinase, CMGC CDK | 0.0052 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.